Table II.

Patients treated with high, moderate or low doses of statins either used in monotherapy or in combination with ezetimibe or fenofibrate

Parameter		Statin therapy overall	Statin monotherapy	Statin with ezetimibe	Statin with fenofibrate	P-value
Number of patients	N (%)	204	91 (44.6)	99 (48.5)	14 (6.9)
Number of patients on different doses of statin N (%)	High	116 (56.9)	39 (42.9)	71 (71.7)	6 (42.9)	< 0.001
	Moderate	81 (39.7)	48 (52.7)	27 (27.3)	6 (42.9)
	Low	7 (3.4)	4 (4.4)	1 (1.0)	2 (14.3)

Doses of statins were applied and assigned as high, moderate, or low based on the guidelines by the Blood Cholesterol Expert Panel from the American College of Cardiology (ACC) and the American Heart Association (AHA) [14].